Background Comparative evidence on the diagnostic yield of endobronchial ultrasound (EBUS)-guided sampling techniques for ...

Evolocumab therapy reduces the risk for major cardiovascular events in stable patients with prior percutaneous coronary intervention.

We go deep on the past, present and future of a statistic that is as polarizing as it is powerful.

Postbiotics are gaining momentum. How can ingredient branding support the accessibility of postbiotics in F&B applications?

After much discussion, the scientific community settled on an estimate of around six million species. This conservative ...

Retrospective single-center review of 80 HFrEF patients added SGLT2 inhibitors on stable guideline-directed therapy, with ...

A new meta-analysis suggests that okra may modestly improve key cardiovascular risk markers in people with diabetes, but researchers warn that the evidence is not strong enough to replace ...

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the ...

Sotatercept was effective and well tolerated in patients with intermediate- to low-risk pulmonary arterial hypertension (PAH) ...

Patients with previously treated metastatic pancreatic cancer lived roughly twice as long when given an oral pill called ...

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

A review included more than 600,000 people to highlight that what we eat—not just what we drink—impacts liver health.